New hope for tough-to-treat pancreatic cancer? early trial tests combo approach
Disease control
Terminated
This early-phase study tested whether adding the experimental drug NIS793 to standard chemotherapy (FOLFIRINOX) is safe and effective for people with metastatic pancreatic cancer. Only 4 participants were enrolled before the study was stopped. The goal was to find the right dose …
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated May 14, 2026 12:06 UTC